Marketresearchnews

Tuesday, 18 May 2021

Maternal health Market to Witness Widespread Expansion During 2020-2027

Market Scenario

Every year the death of women is high because of the pregnancy complications. The number is much reduced in the todays date. The reason behind this is government initiatives, the government is trying to help pregnant women for their better health of mother and baby. The best example of the initiatives can be seen by UNICEF (India). The program they have started is Janani Shishu Suraksha Karyakaram (JSSK) scheme which provides free maternity service across India. The services are provided to increase number of emergency referral systems and maternal death audits, and improvements by government and management for health services. Every year near about 800 women die in the world. India contributes 20% in this number of 800. The number of deaths are being controlled by the WHO, CDC and UNICEF programs. The education is given to women and the health services are provided at large to women. Adolescent women are at risk of the complications during pregnancy, these women are provided with health services. The post pregnancy services are also provided to them.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/732

The maternal health market will grow at a rate of 7% CAGR during the forecasted period 2017-2023. The deaths was found reduced in 2012 it was near approximately 175. This will be further reduced in coming years with the help of scheme like JSSK by UNICEF in India.

Study objectives:

To provide detail analysis of the market structure along with estimated future growth forecast for the next 7years about various segments and sub-segments of the global maternal health market.
To provide insights about factors affecting the market growth.
To analyze the global maternal health market based on various factors - price analysis, supply chain analysis, Porters Five Force Analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - Americas, Europe, Asia-Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market’s segments which includes by type of pregnancy, by risk in pregnancy, by complications, by delivery type.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the global maternal health market.

Segments:

The market of the maternal health is segmented into type of the pregnancy, risk in pregnancy and complications. Types of pregnancy includes Intrauterine, Ectopic, Tubal and Others. On the basis of risk occurred in pregnancy which have high risk and molar risk. On the basis of the complications like miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa and others. The miscarriage further have sub segments like threatened, inevitable, complete, and incomplete.

Regional analysis:

Globally the deaths of women are increasing due to the complications during pregnancy. The market for the maternal health is divided into four main geographic regions. The main regions are Americas, Europe, Asia-Pacific and Middle East and Africa. Further the regions are divided into developed and developing countries falling under this regions. The deaths of women have increased in Americas despite of advanced medicine and technology over past 25years. The reason behind this is of heart conditions, blood pressure, bleeding and many more complications.
Intended Audience

Government hospitals
Private hospitals
NGOs
Medical Organizations and Institutes
Pharmaceutical Companies

Key players of Global Maternal Health Market:

Some of the global and local players are engaged in the maternal health those are, Agile Therapeutics (USA), Fuji Latex Co (Japan), Okamoto industries, Reckitt Benckiser Group Plc.(UK), Sanofi (India), Johnson and Johnson(USA).
The report for Global Maternal Health Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/maternal-health-market-732

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Soaring Demand Drives Global Microfluidics Device Market Growth During the Forecast Period, 2020-2027

Microfluidic devises Market overview

According to the latest report, the global Microfluidic Devices market size is predicted to reach USD 14,296.04 Million by the end of the year 2025 with a significant growth rate of CAGR of 19.70%. A Microfluidic device utilizes the chemical and physical properties of gases and liquids at a micro-scale. This device provides various benefits over evenly sized systems. Microfluidics investigates and uses fewer samples volume, chemicals, and also decreases global fees of applications.

The microfluidic device is an advanced technology that helps integrate several medical tests on a single chip. It is an important technology for miniaturization, integration, industrialization, and parallelization of several tests in different fields of biological research, in developments of drugs, and diagnosis. The rise in demand for the microfluidic technologies for miniaturization of the chip and testing products are the major driving factors for the growth of the Microfluidic Devices market. The increasing demand for genomics and proteomics are some other major driving factors. Moreover, the rigid policies of the government may hamper the growth of the global Microfluidic Devices market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/684

This report contains all the information on the global Microfluidic Devices market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global Microfluidic Devices market and forecast to 2025 is also included in the report.

Covid 19 Analysis

The outbreak of the global pandemic covid 19 has affected the global Microfluidic Devices market, by creating a burden on the laboratories due to the large numbers of cases that were supposed to be tested in the labs. Hence, there is some positive impact as well; Microfluidic is basically handling of a small number of fields in chambers and microscale channels. It helps the researchers to manage fewer amounts of samples and generates faster results as compared to the conventional methods, just because of the high potentials in advanced microfluidic technology. This technology is considered the promising technology in this global pandemic situation of covid 19.

Market Dynamic

Drivers

The advancement in the technology of diagnosis devices is the major factor propelling the growth of the global Microfluidic Devices market. Along with that, the rising incidence of chronic diseases and accordingly increased demand for Microfluidic technology has further boosted the demand for the global Microfluidic Devices market.

Opportunities

The current scenario of the market is witnessing major advancement in technology, as the developments in Microfluidic are leading towards the cost-effective mass production process of diagnostic devices. it is also creating various opportunities for the major key manufacturers in the market as well by pairing smartphones to Microfluidic which enables the deployment of point-of-care testing. The application of Microfluidic devices is likely to boost the demand for the Microfluidic devices market in the future.

Restraints

The lack of skilled technicians in the Microfluidic along with the issues related to the regulatory environment is the major restraint of the global Microfluidic market. The high cost of Microfluidics types of equipment is another major restraint especially in the developing countries as it is unaffordable due to the emerging low income of such countries.

Challenges

The major challenges faced by the key manufacturers of Microfluidic devices are to provide results immediately outside the conventional laboratory environment which involves point-of-care device market (POCT) testing. It is strongly impacting the growth of the global Microfluidic Devices market.

Cumulative Growth Analysis

The increasing advancement in technology is the major key driving factor for the Microfluidic device market. For instance, in the month of January 2019, L’Oreal has launched a prototype of a wearable sensor from the L’Oreal Technology Incubator at the show of Consumers Electronic in 2019 and also introduced a companion app. The first wearable microfluidic sensor was introduced by My Skin Track pH by La Roche-Posay and companion app which helps to easily measure the pH balance in skin and accordingly creates some customized product regimens for better care for the skin.

Value Chain Analysis

According to the latest report the global Microfluidic devices market has been segmented onto the basis of industry, materials, application, and regions. On the basis of industry, the global Microfluidic devices market has been segmented into pharmaceutical, medical devices, in-veto diagnostics, and others. The pharmaceutical segment is further segmented into chips for lab analytics, accurate dispensing devices, and micro-reactors for drug synthesis. The in-veto segments account for the maximum shares of 50.6% in the year 2018 due to the increasing demand for early diagnosis.

On the basis of materials, the global Microfluidic devices market has been segmented into glass, polymer, silicon, and others. The polymer segments account for the maximum share in the global Microfluidic devices market due to its fast fabrication process and cheaper costs as compared to the glass and silicon. On the basis of application the global Microfluidic devices market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

Segmentation Overview

The market is segmented on the basis of the industry, materials, application, and regions. The global Microfluidic devices market is expected to witness decent growth during the forecast period.

By Application

Based on the application, the market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

By End-users

Based on the propulsion types, the market is segmented into pharmaceutical, medical devices, in-veto diagnostics, and others.

Regional Analysis

According to the latest reports, the global Microfluidic devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East, and Africa. America accounts for the maximum share in the global Microfluidic devices market due to the rising geriatric population, increasing chronic diseases and lifestyle diseases, raising awareness in healthcare, and the developments in technologies for several applications and along with that the extensive insurance infrastructure facilities are driving the growth of the global Microfluidic Devices market.

Europe is expected to stand second in the global Microfluidic devices market due to advancements in technology and the support of the major levy players for the growth of the Microfluidic devices market. Asia Pacific is predicted to register the maximum CAGR during the forecast period due to the introduction of new advanced products in these regions. The Middle East & Africa holds the least Microfluidic devices market share due to the low development in the economy mainly in the African region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microfluidics-device-market-684

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global G-Protein Coupled Receptors Market size and forecast, 2020-2027

Market Forecast

G-Protein Coupled Receptors Market trends is expected to cross USD 4,200 Million by 2025 at a CAGR of 7.1% during the forecast period.

The growing use of G-protein coupled receptors in medicate disclosure and advancement forms is set to drive the demand of G protein-coupled receptors.

G-protein coupled receptors are most commonly prescribed for the treatment of cardiovascular disease, oncology, immunology, respiratory system, central nervous system (CNS), and others. GPCRs (G-protein coupled receptors) play a physiological role in the regulation of cardiac function in both health and disease and thus represent one of the largest class of surface receptors targeted by drugs.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8356

Market Synopsis

There is an increase in government support in R&D activities in the global G-protein coupled receptors market.

The government is supporting research & development for biosensors, orphan drug receptors, sedate targets, and high-throughput screening methods to bind the nucleotides guanosine triphosphate (GTP) and guanosine diphosphate (GDP).

Market Influencers

An increasing number of allosteric modulators, biological drugs, and biased agonists that target the receptors accelerate the demand for assays in G-protein coupled receptors market.

Market Drivers

The increasing number of drugs under clinical and preclinical studies that target these receptors. Approximately, in 2018, there were 19% of drugs under clinical trial phase 1 which targets G protein-coupled receptors
Existence of a variety of agents that stimulate GPCR activity. The drugs salmeterol and albuterol, bind and activate beta-adrenergic GPCRs, stimulate airway opening in the lungs and thus are used in the treatment of some respiratory conditions, including chronic obstructive pulmonary disease and asthma.
The growing use of G-protein coupled receptors in medicate disclosure and advancement forms.
Increasing number of allosteric modulators, biological drugs, and biased agonists that target these receptors.
Presence of a large number of approved drugs that target G-protein coupled receptors. In 2018, there were approximately 700 approved drugs that target G protein-coupled receptors (GPCRs).

Market Restraints

High cost involved in the maintenance of GPCR cell lines.
Stringent government policies

Segmentation

By Product

Cell Lines: Cell lines play a significant role in the cellular impedance assays for the detection of GPCR targets.

Detection Kits: Fastest segment as detection kits are easy to use, robust, and highly sensitive products to evaluate the activity through different pathways.

Cell Culture Reagents: Largest segment as it is one of the most conventional and affordable ways of use with effective

Ligands: Ligands stabilize G protein-coupled receptors and affect its functions. GPCR binds with many different types of ligands.

By Assay Type

Calcium Functional Assays: Fastest segment. Due to the numerous advantages associated with the use of calcium flux assays. The benefits include high sensitivity, user configurability, ease in the estimation of calcium flux.
cAMP Functional Assays: It is cyclic adenosine monophosphate (cAMP). It is an essential intracellular second messenger in GPCR.
cGMP Assays: Acyclic guanosine monophosphate (cGMP) assay provides a competitive immunoassay for sensitive and quantitative determination of cGMP level in biological samples.
GTP Gamma S Binding Assays: It can be used to differentiate agonist, antagonist, and inverse agonist activities.
ß-Arrestin Functional Assays: It helps in the activation of GPCRs and helps in the regulation of other signaling molecules such as protein kinases.
Internalization Assays: It monitors the internalization and recycling patterns of activated GPCRs.
Others: Others include reporter gene assays, trafficking Assays.

By Application

Cardiovascular System: Largest segment. The β-adrenergic receptors and angiotensin II receptors provide therapy for a wide range of cardiovascular disease, which includes coronary artery disease, hypertension, and heart failure. About 610,000 people die of heart disease in the US every year.
Oncology: GPCR controls features of tumorgenesis, that includes immune cell-mediated function, invasion, proliferation at the secondary site. In 2018, approximately 1,735,350 new cases of cancer were diagnosed in the US.
Immunology: GPCRs bind to various metabolites and transmit signals that are important for proper immune and metabolic functions.
Respiratory System: GPCRs mediates various airway smooth muscle functions that include contraction, growth, and synthetic functions that orchestrate airway inflammation and promote remodeling of the airway.
Central Nervous System: GPCRs plays a vital role in the pathophysiology of different diseases and disorders that include anxiety, depression, schizophrenia, and epilepsy.
Others: Others include metabolism and inflammation.

By Region

Americas: The largest regional market owing to the strategic investments in cancer research that would drive the growth of G protein-coupled receptors market.

Europe: Rising number of approved drugs that target GPCRs would drive the demand for G protein-coupled receptors market in this region. In November 2017, 134 GPCR targets for drugs were approved in European Union, and 128 targets were listed in the food and drug administration (FDA) orange book, thus driving the growth of G protein-coupled receptors market in this region.

Asia-Pacific: Fastest segment. Due to the presence of several emerging companies such as HD Biosciences Co. Ltd., NB Health Laboratory. An increasing number of growth initiatives taken by companies to improve their market presence will drive the growth of G protein-coupled receptor in this region.

Middle East & Africa: Increasing healthcare expenditure and rising government funding drive the demand for the G-protein coupled receptors market in this region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/g-protein-coupled-receptors-market-8356

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Healthcare IoT Security Market size and forecast, 2020-2027

In traditional times patients used to book appointments with doctors for their check-ups and routine calls or used to use the medium of phones to connect with doctors limiting the point of contact and communication. But, with the introduction of the internet of things, patients and doctors were connected using the internet in the healthcare department. Now doctors can monitor their patients remotely using cameras, microphones, teleprompters, etc. Artificial intelligence with machine learning developed programs ad algorithms for healthcare departments for countries to track and record patient-doctor data which can be used globally concerning patient’s consent. With increased global access to healthcare IoT (Internet of Things), security solutions were introduced to maintain the security and decorum of the medical industry.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/946

With modernization, technology has boosted to a greater level which has led the hospitals to come to homes for tracking and maintaining patients. The introduction of insulin pumps, pacemakers, heartbeat monitors, nasal pumps, and other devices like smartphones and watches to monitor human health has made for the healthcare IoT security market. Government and private organizations play a vital role in maintaining the security of all the home hand-held devices and healthcare institutions. Healthcare IoT Security Market Research Report forecasts a CAGR of 39.5% by the year 2025 by generating a revenue of more than 100,000 Million US dollars per year.

COVID-19 Analysis:

In the November of 2019, the world woke up to an outbreak of a worldwide pandemic that affected countries economically and politically. With the immense loss of man-power countries, economical wealth came to a stand-still. Many countries like Russia, Italy, Brazil, etc. population was diminished to a considerable amount and other countries like the US, India, UK, etc. are facing a rise in active COVID-19 cases on daily basis. Global lockdowns were imposed countrywide and further state-wise to contain the spread of the virus. The Healthcare industry in coordination with the government has played a vital role in tracking and recording the patients and treating them. Healthcare IoT Security Market has shown a boost due to an increased state of emergency to isolate the patients depending on their symptoms and treating them accordingly. Sharing patient’s data is at risk and can hamper patient’s credibility thus highly secure systems were imposed to share the information across the network.

Healthcare IoT security Market Dynamics:

Drivers:

Healthcare IoT Security Market trends are on the verge of growing globally due to the increased demand for real-time data processing of patient records. More customers are inclined in booking doctor’s appointments online using hospital services that maintain a schedule between doctor and customer. This helps in the time saving of both customers and doctors by helping in removing the waiting queue. The government of all the 213 countries in the world is concerned with patient-doctor confidentiality thus has imposed HIPPA training for hospital employees to adhere to security. Nowadays our smartphones and watches are acting as health tracking data like a heartbeat monitor, blood pressure, insulin levels, oxygen levels, glucose levels, etc. which needs to be secured to avoid cybercrimes.

Challenges:

The major threats that involve the healthcare IoT security industry are easy passwords, poor authentication, loss of data while transfer due to poor network, and other cybercrimes. With an increase in the world’s population, there is an increase in patient inventory thus storing the data on-premise has become tougher with time. Thus, cloud-based storage came into the picture. On one hand, this led to easy data access and communication between doctors and patients, but on the other hand, cyber hacking and attacks on internet-connected devices became more vulnerable due to non-secure networks and failed fireball protections.

Technology Analysis:

Conventional storage systems are no prompted in healthcare systems due to the introduction of artificial intelligence (to predict the early onset of diseases by analyzing the patient’s recording using deep learning). Thus, IoT (Internet of Things) was introduced in the healthcare department where patient’s illness history, bill payments, mode of payment, name, age, date of visit, etc. were recorded and stored in hospitals inventory. This in turn is shared across platforms using network hubs making a well-connected healthcare system. To maintain cybersecurity government has imposed rules and regulations that each healthcare institution must follow while implementing IoT in the regions to maintain customer satisfaction and security. Intel recently has made a statement about IoT in healthcare security which states that healthcare IoT security market share is expected to rise by more than 2.5 Billion US dollars by the year 2025.

Segment Overview:

By Type:

Healthcare IoT Security Market is segmented as identity management, data loss prevention, access management, data encryption, threat management, system virus management, and data analysis. When a hospital or healthcare center implements IoT Security measures it must follow protocols to maintain security against threats and cybercrimes. A secured ERP system is made for entering the customer’s data with is stored in XML files secured by passwords. Virus protection software is installed to fight against unnecessary threats of computer and internet viruses while uploading and downloading documents. Firewalls are initiated to provide prevention against hacking of hardware devices associated with patient monitoring.

By Vertical:

Healthcare IoT Security Market is segmented majorly into three categories based on vertical namely: biotechnology (used to maintain the security of user data), Pharma security (used to maintain the security of pharma department against unnecessary threats towards the drug testing or discovery of new drugs or sabotaging the contents of already authorized drugs) and medical device security ( used to avoid the hacking of hardware devices associated with patient monitoring).

Regional Analysis:

Healthcare IoT security market trends show development in the private and public healthcare sector where authorities are more concerned with maintaining the industrial standards with agreeing to government regulations. North America is the top-most player when it comes to Healthcare IoT security by securing a global market share of more than 40% in regional accounting and adapting healthcare services to IoT security and privacy. Europe (Russia, Germany, etc.) has contributed about 20% to the global healthcare security market by adhering to global security standards. Asia-Pacific (China, Japan, India, Singapore) have contributed about 40% to new clinical trials of chronic diseases as read by WHO contributing to the rapid increase of the healthcare IoT security industry. Independently Asia-Pacific regions have contributed a CAGR of 47% to the healthcare industry rising the market quotient and revenue by about 2.8 million dollars in the past decade.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-iot-security-market-946

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Tissue Microarray Market to Witness Widespread Expansion During 2020-2027

The Global Tissue Microarray Market is expected to register a CAGR of 10.54% and is anticipated to reach USD 10,914.54 million by 2023. Tissue microarrays are paraffin blocks that are created by separating cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a microarray at defined array coordinates. With the help of tissue microarray, up to at least 1000 tissue samples can be arrayed into a single paraffin piece. It allows simultaneous analysis of molecules present in DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide. This adaptable strategy, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.

The increasing application in drug discovery, increasing prevalence of cancer, growing advancements in biotechnology and pharmaceutical companies, and rising demand for cost-effective and accurate diagnostic methods are the major drivers propelling market growth. However, tissue microarray may not be fruitful for heterogeneous cancers, which is likely to constrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1213

Market Dynamics

The prevalence of cancer is one of the crucial factors that drive the growth of the tissue microarray market. According to the American Cancer Society, in 2017, nearly 13% of all cancers diagnosed in adults aged 20. It further stated that rates of liver cancer, thyroid cancer, and melanoma are increasing from last few years. According to US Breast Cancer Statistics, about 1 in 8 US women (about 12%) will develop invasive breast cancer throughout their lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer were expected to be diagnosed in women in the US, along with 63,410 new cases of non-invasive (in-situ) breast cancer.

Moreover, increasing advancements in biotechnology and pharmaceutical companies and growing demand for cost-effective and accurate diagnostic methods have fueled the growth of the market. On the other hand, tissue microarray is that it may not be fruitful for heterogeneous cancers anticipated to hamper the market growth.

Segmentation

The global tissue microarray market has been divided into the procedure, technology, application, and end user. By procedure, the market has been segregated into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array. Based on technology, the market has been segmented into DNA microarray, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, and western blotting. Based on the application, the market has been bifurcated into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, comparative genomic hybridization, and sequencing bioinformatics. By end-user, the market has been classified as pharmaceutical and biotechnological companies and research organization. The research organization segment accounted for a market value of USD 1876.02 million in 2016.

Key Players

The prominent players in the global tissue microarray market dynamics are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.

Some of the key strategies followed by the players operating in the global immunoassay in the R&D market were innovation, product development, acquisition, and expansion.

Regional Analysis

The global tissue microarray market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global tissue microarray market during the forecast period. This is attributed to the increase in the prevalence of cancer in the Americas, leading to the requirement for tissue microarrays. Besides, increasing application in drug discovery is also responsible for the growth of the market. Europe holds the second position in the market. Increasing emphasis on rapid diagnosis and treatment of cancer and infectious diseases, change in lifestyle, and high prevalence of cancer among geriatric population drives this market in Europe.

Additionally, the companies operating in the market are mainly focusing on mergers and acquisition, which is expected to support market growth. Asia-Pacific is expected to be the fastest-growing market for tissue microarray. Increasing prevalence of cancer, awareness among the people about their health, and changing lifestyle contribute to the growth of this market. In the Asia-Pacific region, China accounted for a market share of 21% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to the lack of advanced medical facilities and less improvement in the healthcare domain.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Healthcare Supply Chain Management Market size and forecast, 2020-2027

The global healthcare supply chain management market is expected to grow significantly over the forecast period. It is estimated that the global healthcare supply chain management market is expected to register a CAGR ~ 8.2 % during the forecast period from 2018 to 2023. Supply-chain management is a process which includes planning, design, execution, control, and monitoring flow of various goods and services to create competitive logistics infrastructure, increases net value, synchronizing demand and supply of goods to measure performance. The major driving factors of supply chain management in healthcare are increasing globalization, expanding business, fast product life cycle, increasing fragmentation in the healthcare industry, the high economy of scale and other. The other factors responsible to support the market are increasing customer demand, rising customization, growing capabilities of technology and other. However, factors like lack of awareness, low innovation, the high cost of maintenance and installation, issues of integration may restrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2030

Healthcare Supply Chain Management Market Regional Summary

Geographically, the Americas is anticipated to dominate the global healthcare supply chain management market owing to the developed healthcare sector, the presence of a large number of top biotech and pharmaceutical companies there, along with government initiatives, and rising technological advancement, increase in demand of medical devices. In the International Trade Administration 2016 report according to Government Accountability Office's (GAO) statistics, the US generated approximately USD 45 billion by exporting medical devices in 2015. The exporting of medical devices and generating a large amount of revenue support the supply chain management in the healthcare sector.

Europe is expected to hold the second largest position in the global healthcare supply chain management market. According to the European Commission, June 2017, publication Europe is one of the world’s leading exporter of pharmaceutical and medicinal products. Also, in 2016 Europe accounted for EUR 144 billion, by exporting pharmaceutical product worldwide. The increase in import and export for healthcare related products will enhance Healthcare supply chain management market in this region.

Asia-Pacific is expected to be the fastest growing region in the market due to the rising prevalence of chronic disease and an increase in the demand for pharmaceutical products & medical devices. Also, increased expenditure in the healthcare sector is expected to enhance the growth in this market. On the other hand, the Middle East & Africa accounts the lowest Healthcare supply chain management market share. Healthcare supply chain management market of this region is expected to be held by the Middle Eastern region due to a developed healthcare sector and growing government initiatives for the healthcare sector.

Healthcare Supply Chain Management Market Segmentation

The Healthcare supply chain management market has been segmented into models, functions, delivery mode, software, technology, and end users. The market, on the basis of models, has been segmented into, build-to-order, make-to-stock model, continuous replenishment model, chain assembly and others.

On the basis of function, Healthcare supply chain management market is sub-segmented into forecasting and planning, warehousing and distribution, inventory management and procurement, internal logistics and operations, reverse and extended logistics and others.

On the basis of delivery mode, Healthcare supply chain management market further segmented into on-premise, web-based, and others.

On the basis of software, Healthcare supply chain management market is sub-segmented into planning tools and execution tools. The planning tools are sub-segmented into forecasting and inventory management, supplier and vendor management, production and sales planning, others. Execution tools are further sub-segmented into warehouse management, order processing and status tracking, others. On the basis of technology, the market is sub-segmented into a barcode, radio frequency identification (RFID), global positioning system (GPS), internet of things and big data, others. On the basis of end users pharmaceutical and biotech companies, logistics companies and distributors, healthcare providers, and others.

Healthcare supply chain management market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Healthcare supply chain management market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European healthcare supply chain management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The healthcare supply chain management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Healthcare supply chain management market in the Middle East & Africa has been segmented into the Middle East and Africa.

Healthcare Supply Chain Management Market Key players

The major key players of the global healthcare supply chain management market include SAP (Germany), Infor (US), Oracle (US), GHX (US), TECSYS (Canada), McKesson (US), Manhattan Associates (US), Jump Technologies (US), JDA Software (US), and LogiTag Systems (Israel), Advocate Health Care (Murray, UT), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-supply-chain-management-market-5716

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Home Healthcare Market Growth, Trends and Value Chain 2020-2027

The global home healthcare industry is anticipated to expand at 8.1% CAGR from 2019 to 2027 (forecast period), according to the latest report by Market Research Future (MRFR). Home healthcare is an increasing viable option being preferred by patients owing to increasing healthcare costs and the burgeoning geriatric population. Home healthcare provides a range of services including physical therapy, speech therapy, occupational therapy, and skilled nursing. The digitization of data has made it simpler for patients to contact physicians and clinicians and gain an accurate diagnosis from the comforts of their home.

Technological advances in healthcare and diagnosis equipment and government initiatives encouraging home healthcare are likely to fuel market demand in the forthcoming years. Taking a cue from patient demands, players such as Philips have launched wireless solutions. This is evident by the introduction of CarePoint 5.0, a easy-to-use nurse call system for senior citizens in assisted living facilities and bedridden patients recuperating at home. But concerns regarding patient safety can impede market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2030

Home Healthcare Market Overview

The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. MRFR’s report includes a thorough analysis of the global home healthcare market segmented by product, service, software, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.

Segment Overview

The global home healthcare market is segmented by product, service, software, and region. Products in the market include therapeutic and testing, screening, and monitoring products. The former is sub-segmented into dialysis equipment, respiratory therapy equipment, IV equipment, insulin delivery devices, wound care products, and others. On the other hand, the latter is segmented into holter and event monitors, pulse oximeters & heart rate monitors, sleep apnea monitors, blood glucose monitors, blood pressure monitors, cholesterol monitoring devices, and others.

Software discussed in the report designed to alleviate patient and hospital troubles include hospice solutions, telehealth solution, agency software, and clinical management systems. Based on services, the market is segmented into skilled nursing services, unskilled care services, respiratory therapy services, rehabilitation therapy services, infusion therapy services, and pregnancy care services.

The segments covered in the report are analyzed with respect to four major regions – North America, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. The definition and advantages of “home healthcare” is outlined in the report for a comprehensive understanding of the market. The report discusses in detail the various players and their respective strategies to enhance their value chain.

Competitive Landscape

Some of the key players in the home healthcare market include Koninklijke Philips N.V. (The Netherlands), F. Hoffmann-La Roche AG (Switzerland), A&D Company (Japan), Fresenius SE & Co KGaA (Germany), Abbott (U.S.), GE Healthcare (U.S.), McKesson Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton Dickinson Company (U.S.), Omron Corporation (Japan), Medtronic PLC (U.S.), LG Electronics (South Korea), Kinnser Software (U.S.), Apple (U.S.), 3M (U.S.), and others. These players are engaged in partnerships to launch new products in the market and expand their consumer base.

The report offers comprehensive profiles on these market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are discussed in granular detail.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/home-Healthcare-market-2030

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com